Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Stopping GLP-1 Medications May Raise Heart Risk, New Study Finds New research reveals the cardiovascular benefits of GLP-1 drugs build slowly but erode quickly, with two years off the medication raising cardiac risk by as much as 22%
Understanding why this happens and how to manage it can help patients continue their treatment comfortably while achieving their therapeutic goals
Different mechanisms like insulin resistance, inflammation, abnormalities in the metabolism of lipid, adipokine balance and endothelial function have been proposed [4]
This matters most for medicines with tight dosing windows or those that need consistent absorption
In the search for validating, science-backed management strategies, researchers and clinicians have increasingly focused on the intricacies of mitochondrial health and cellular metabolism
